Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PRPO

Precipio Inc

Dec 13 • 04:00PM ET

5.82

Dollar change -0.42
Percentage change -6.71	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: HOLX BIO DGX LH NTRA NEO QGEN VERI CDNA FLGT

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.06	Insider Own	13.19%	Shs Outstand	1.48M	Perf Week	0.63%
Market Cap	8.05M	Forward P/E	-	EPS next Y	-	Insider Trans	0.55%	Shs Float	1.29M	Perf Month	-8.33%
Income	-3.00M	PEG	-	EPS next Q	-	Inst Own	4.24%	Short Float	0.36%	Perf Quarter	-8.62%
Sales	17.41M	P/S	0.46	EPS this Y	-	Inst Trans	-50.47%	Short Ratio	0.68	Perf Half Y	0.54%
Book/sh	8.06	P/B	0.72	EPS next Y	-	ROA	-16.66%	Short Interest	0.00M	Perf Year	-14.77%
Cash/sh	0.76	P/C	7.67	EPS next 5Y	-	ROE	-24.11%	52W Range	4.31 - 7.30	Perf YTD	-10.44%
Dividend Est.	-	P/FCF	-	EPS past 5Y	56.09%	ROI	-24.05%	52W High	-20.26%	Beta	1.41
Dividend TTM	-	Quick Ratio	0.60	Sales past 5Y	43.42%	Gross Margin	34.23%	52W Low	35.06%	ATR (14)	0.27
Dividend Ex-Date	-	Current Ratio	0.73	EPS Y/Y TTM	72.65%	Oper. Margin	-27.19%	RSI (14)	43.85	Volatility	4.70% 3.79%
Employees	57	Debt/Eq	0.11	Sales Y/Y TTM	31.31%	Profit Margin	-17.23%	Recom	1.00	Target Price	19.00
Option/Short	No / Yes	LT Debt/Eq	0.04	EPS Q/Q	59.47%	Payout	-	Rel Volume	5.83	Prev Close	6.24
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	15.29%	Earnings	Nov 18 AMC	Avg Volume	6.75K	Price	5.82
SMA20	-2.20%	SMA50	-7.03%	SMA200	-3.23%	Trades		Volume	39,366	Change	-6.71%

Nov-20-24 08:00AM	Precipio Inc (PRPO) Q3 2024 Earnings Call Highlights: Strong Growth in Diagnostic Services and ... (GuruFocus.com)
Nov-06-24 05:00PM	Precipio Announces Q3-2024 Shareholder Update Call (GlobeNewswire)
Oct-08-24 10:00AM	Precipio Expands Bloodhound MPN Panel by Adding CALR Mutation Subtyping (GlobeNewswire)
Sep-06-24 04:00PM	Precipio Announces Employee Stock Option Plan Repricing (GlobeNewswire)
Aug-15-24 05:00PM	Precipio Announces Q2-2024 Shareholder Update Call (GlobeNewswire) +5.96%
09:00AM	Loading…
Jul-25-24 09:00AM	Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven (GlobeNewswire) +8.01%
Jul-17-24 09:00AM	Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 (GlobeNewswire) +23.87%
Jun-13-24 04:00PM	Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders (GlobeNewswire)
Jun-12-24 04:00PM	Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting (GlobeNewswire)
09:00AM	Precipio Provides Status Update on Current Business Matters (GlobeNewswire)
May-15-24 08:52AM	PRPO Stock Earnings: Precipio Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-06-24 05:00PM	Precipio Secures a short-term $500K Credit Facility (GlobeNewswire)
Apr-01-24 10:53AM	PRPO Stock Earnings: Precipio Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
Mar-25-24 05:00PM	Precipio Announces Year end 2023 Shareholder Update Call (GlobeNewswire)
Feb-13-24 10:00AM	Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY (GlobeNewswire)
10:00AM	Loading…
Feb-06-24 10:00AM	Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for Cancer (GlobeNewswire) +8.24%
Jan-23-24 10:00AM	Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter (GlobeNewswire)
Jan-17-24 10:30AM	Precipio Signs Distribution Agreement For IV-Cell and HemeScreen in Japan (GlobeNewswire) +15.37%
Jan-02-24 09:00AM	Precipio Announces Christina Valauri joins the Board of Directors (GlobeNewswire)
Dec-14-23 04:30PM	Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 (GlobeNewswire) +12.40%
Nov-16-23 05:00PM	Precipio Announces Q3-2023 Shareholder Update Call (GlobeNewswire) -7.74%
Oct-18-23 09:00AM	Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022 (GlobeNewswire)
Oct-03-23 10:00AM	Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023 (GlobeNewswire)
Sep-28-23 09:00AM	Precipio Continues to Sign New HemeScreen Customers (GlobeNewswire)
Sep-25-23 11:00AM	Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven (GlobeNewswire)
Sep-21-23 09:00AM	Precipio Takes Final Step Towards Regaining Nasdaq Compliance (GlobeNewswire) -10.41%
Sep-13-23 09:30AM	Precipios Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan (GlobeNewswire) +7.80%
Aug-31-23 03:26PM	11 ChatGPT Penny Stock Picks (Insider Monkey)
Aug-19-23 06:01AM	Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-13-23 10:16AM	Precipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full Story (Simply Wall St.)
05:00PM	Loading…
Aug-10-23 05:00PM	Precipio Announces Q2-2023 Shareholder Update Call (GlobeNewswire)
Aug-08-23 09:00AM	Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel (GlobeNewswire)
Aug-03-23 09:00AM	Precipios Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven (GlobeNewswire)
Aug-01-23 09:00AM	Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023 (GlobeNewswire) +5.74%
Jun-14-23 09:49AM	Precipios Omnia Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy (GlobeNewswire)
Jun-13-23 09:00AM	Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology (GlobeNewswire)
Jun-08-23 08:30AM	Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) -29.40%
Jun-07-23 09:30AM	Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects (GlobeNewswire) +15.23%
May-22-23 11:00AM	Precipios Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology (GlobeNewswire)
May-17-23 04:00PM	Precipio Shares Growth Catalysts For HemeScreen (GlobeNewswire)
May-15-23 04:00PM	Precipio Announces Q1-2023 Shareholder Update Call (GlobeNewswire)
May-04-23 01:00PM	Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division (GlobeNewswire) -6.71%
10:00AM	Precipio Signs Another HemeScreen Customer (GlobeNewswire)
Apr-27-23 05:00PM	Precipio Granted 180-day Extension From NASDAQ To Regain Compliance (GlobeNewswire)
Apr-19-23 11:00AM	Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined (GlobeNewswire)
Apr-09-23 10:25AM	Precipio, Inc. (NASDAQ:PRPO) Q4 2022 Earnings Call Transcript (Insider Monkey)
Apr-02-23 08:55AM	Precipio Full Year 2022 Earnings: US$0.54 loss per share (vs US$0.40 loss in FY 2021) (Simply Wall St.)
Mar-28-23 05:00PM	Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call (GlobeNewswire)
Mar-21-23 10:30AM	Precipio Ships First IV-Cell® Order to Major US Healthcare System (GlobeNewswire)
Mar-07-23 12:49PM	CORRECTION -- Precipio continues to sign up and onboard HemeScreen customers (GlobeNewswire)
12:00PM	Precipio continues to sign up and onboard HemeScreen customers (GlobeNewswire)
Feb-14-23 11:44AM	ThermoFisher Salesforce Votes Precipios HemeScreen® as Best New Product (GlobeNewswire)
Jan-11-23 10:00AM	Precipio Signs Another Major HemeScreen Customer (GlobeNewswire) +7.21%
Dec-06-22 10:00AM	Precipio Signs Additional Major HemeScreen Customer (GlobeNewswire)
Nov-07-22 10:30AM	Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference (GlobeNewswire)
Nov-02-22 05:00PM	Precipio Announces Third Quarter Shareholder Update Call (GlobeNewswire)
Oct-18-22 09:07AM	Precipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Future (Simply Wall St.)
Sep-15-22 11:00AM	Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen (GlobeNewswire) +8.33%
Aug-24-22 11:00AM	Sharon Robins Joins Precipios Products Division as Senior Director of Laboratory & Hospital Sales (GlobeNewswire)
Aug-16-22 11:00AM	Precipio Launches New 1-Step Technology for all HemeScreen Assays (GlobeNewswire) -10.67%
Aug-10-22 10:00AM	Toni-Ann Mills Joins Precipios Products Division to Lead Channel Partner Training, Learning & Development (GlobeNewswire)
Aug-08-22 10:00AM	Precipio Announces Second Quarter Shareholder Update Call (GlobeNewswire)
Jul-20-22 10:30AM	Precipio to distribute HemeScreen® through Fisher Healthcare channel (GlobeNewswire)
Jun-14-22 02:00PM	Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote (GlobeNewswire)
Jun-13-22 11:00AM	Keith Meadors Joins Precipio to Lead its Products Division (GlobeNewswire) -9.40%
May-24-22 10:30AM	Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in Europe (GlobeNewswire)
May-11-22 08:15AM	When Will Precipio, Inc. (NASDAQ:PRPO) Breakeven? (Simply Wall St.) -11.40%
May-10-22 10:30AM	Precipio Signs First IV-Cell Customer Agreement (GlobeNewswire) +15.91%
Apr-26-22 10:00AM	Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference (GlobeNewswire)
Mar-22-22 06:00PM	Precipio Announces 2021 Fourth Quarter and Year-End Shareholder Update Call (GlobeNewswire)
Mar-21-22 05:00PM	Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFO (GlobeNewswire)
Feb-24-22 10:00AM	Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022 (GlobeNewswire)
Nov-29-21 07:27AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +7.33%
Nov-18-21 10:00AM	New York State Approves Precipios HemeScreen for POL clinical use (GlobeNewswire)
Nov-03-21 08:00AM	89bio Announces Appointment of Kathy LaPorte to its Board of Directors (GlobeNewswire)
Nov-01-21 05:00PM	Precipio Announces Q3-2021 and year-end Shareholder Update Call (GlobeNewswire) +10.38%
03:54PM	Precipio (NASDAQ:PRPO) shareholders have endured a 44% loss from investing in the stock three years ago (Simply Wall St.)
Aug-26-21 10:00AM	American Oncology Network Partners with Precipio to Bring HemeScreen® into AONs Laboratory (GlobeNewswire) +5.52%
Aug-20-21 05:00PM	Precipio Reschedules Q2-2021 Shareholder Update Call (GlobeNewswire)
Aug-13-21 10:48AM	Precipio Corrects Announcement of Q2-2021 Shareholder Update Call (GlobeNewswire)
Aug-12-21 05:00PM	Precipio Announces Q2-2021 and year-end Shareholder Update Call (GlobeNewswire)
Jul-28-21 10:00AM	Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M (GlobeNewswire)
Jun-15-21 11:00AM	Precipio Terminates its Equity Line (GlobeNewswire) -5.51%
Jun-08-21 10:30AM	Precipio Launches HemeScreen® Anemia Panel, a One-of-its-Kind Testing Tool (GlobeNewswire) +18.47%
May-20-21 03:15PM	Precipio, Inc. to Host Earnings Call (ACCESSWIRE) +14.77%
May-14-21 04:30PM	Precipio Announces Q1-2021 and year-end Shareholder Update Call (GlobeNewswire) +15.27%
May-10-21 10:30AM	Precipio Launches New HemeScreen Panel for AML, with an unparalleled 4-hour turnaround-time (GlobeNewswire) +15.62%
May-05-21 10:14AM	Investors Who Bought Precipio (NASDAQ:PRPO) Shares A Year Ago Are Now Up 688% (Simply Wall St.)
May-04-21 02:41PM	Indias COVID-19 case tally tops 20 million after nearly doubling in three months (MarketWatch) +6.06%
07:42AM	UPDATE: Precipio shares soar 32% premarket after rapid COVID test becomes available on Amazon (MarketWatch)
04:43AM	Precipio Maintains Momentum After 172% Jump (TheStreet.com)
04:42AM	Premarket Movers Tuesday - Pfizer, CVS Health, Precipio (TheStreet.com)
May-03-21 10:41AM	Precipio Soars on Launch of COVID-19 Antibody Test on Amazon (TheStreet.com) +171.98%
09:30AM	Precipio Launches its Rapid COVID-19 Antibody test on Amazon Platform (GlobeNewswire)
Apr-26-21 11:00AM	Current Signed Customers Expected to Generate $1M Annualized Reported Revenues from Precipios HemeScreen POL Offering by Q4-2021 (GlobeNewswire)
Apr-05-21 09:00AM	Precipio Enters Into an At-The -Market (ATM) Financing Arrangement (GlobeNewswire)
Mar-31-21 03:15PM	Precipio, Inc. to Host Earnings Call (ACCESSWIRE)
Mar-30-21 09:00AM	Precipio Announces 95% Annual Growth YoY and 180% Quarterly Growth YoY (GlobeNewswire) +7.17%
Mar-18-21 04:30PM	Precipio Announces Q4-2020 and year-end Shareholder Update Call (GlobeNewswire)
Mar-03-21 01:00PM	Mr. Ron Andrews joins Precipios Board of Directors (GlobeNewswire) -5.98%

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SANDBERG RICHARD A	Director	Dec 13 '24	Buy	5.80	15,000	87,000	19,525	Dec 13 04:35 PM
SANDBERG RICHARD A	Director	Dec 13 '24	Sale	6.20	12,000	74,400	4,525	Dec 13 04:35 PM
SANDBERG RICHARD A	Director	Dec 11 '24	Proposed Sale	5.90	14,034	82,800		Dec 11 10:22 AM
SANDBERG RICHARD A	Director	Nov 11 '24	Sale	6.28	2,000	12,558	16,525	Nov 12 07:18 PM
SANDBERG RICHARD A	Director	Nov 11 '24	Proposed Sale	6.03	2,000	12,055		Nov 12 09:03 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRPO

Precipio Inc

Upgrade your FINVIZ experience